D.H.J. Jager

1.5k total citations
47 papers, 1.1k citations indexed

About

D.H.J. Jager is a scholar working on Surgery, Periodontics and Physiology. According to data from OpenAlex, D.H.J. Jager has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 19 papers in Periodontics and 18 papers in Physiology. Recurrent topics in D.H.J. Jager's work include Salivary Gland Disorders and Functions (18 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers) and Oral Health Pathology and Treatment (11 papers). D.H.J. Jager is often cited by papers focused on Salivary Gland Disorders and Functions (18 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers) and Oral Health Pathology and Treatment (11 papers). D.H.J. Jager collaborates with scholars based in Netherlands, Germany and United States. D.H.J. Jager's co-authors include H.S. Brand, M.C.D.N.J.M. Huysmans, A.M. Vieira, J. Ruben, Tymour Forouzanfar, G. Hartung, C. Renner, A. Amelsberg, P. Tanswell and Salah‐Eddin Al‐Batran and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

D.H.J. Jager

46 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.H.J. Jager Netherlands 18 310 253 243 233 186 47 1.1k
Smruti Pushalkar United States 15 271 0.9× 366 1.4× 202 0.8× 50 0.2× 143 0.8× 24 1.1k
Collin Jacobs Germany 17 147 0.5× 79 0.3× 62 0.3× 269 1.2× 134 0.7× 71 955
Mitsuyoshi Iino Japan 19 152 0.5× 214 0.8× 220 0.9× 39 0.2× 205 1.1× 104 1.3k
Elizabeth Ferreira Martinez Brazil 19 127 0.4× 133 0.5× 52 0.2× 238 1.0× 284 1.5× 133 1.2k
Manabu Habu Japan 21 152 0.5× 69 0.3× 96 0.4× 181 0.8× 312 1.7× 93 1.3k
Marjan Nokhbehsaim Germany 23 65 0.2× 451 1.8× 134 0.6× 78 0.3× 75 0.4× 55 1.2k
Leila Jahangiri United States 21 92 0.3× 125 0.5× 98 0.4× 293 1.3× 87 0.5× 64 1.2k
Jean‐Luc Veyrune France 16 134 0.4× 100 0.4× 85 0.3× 140 0.6× 34 0.2× 30 859
Setsuko Uematsu Japan 12 143 0.5× 185 0.7× 52 0.2× 164 0.7× 36 0.2× 27 795
Maria Fernanda Setúbal Destro Rodrigues Brazil 20 167 0.5× 97 0.4× 75 0.3× 43 0.2× 90 0.5× 74 995

Countries citing papers authored by D.H.J. Jager

Since Specialization
Citations

This map shows the geographic impact of D.H.J. Jager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.H.J. Jager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.H.J. Jager more than expected).

Fields of papers citing papers by D.H.J. Jager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.H.J. Jager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.H.J. Jager. The network helps show where D.H.J. Jager may publish in the future.

Co-authorship network of co-authors of D.H.J. Jager

This figure shows the co-authorship network connecting the top 25 collaborators of D.H.J. Jager. A scholar is included among the top collaborators of D.H.J. Jager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.H.J. Jager. D.H.J. Jager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wermke, Martin, Sebastian Ochsenreither, Manik Chatterjee, et al.. (2024). 1001MO Initial safety, pharmacokinetics, and anti-tumor activity data of TCER IMA401, a MAGEA4/8-directed half-life extended TCR bispecific, in phase I dose escalation. Annals of Oncology. 35. S681–S682. 2 indexed citations
2.
Brand, H.S., et al.. (2023). Knowledge of diagnosis and management of selected oral mucosal lesions among dentists in The Netherlands. Medicina oral, patología oral y cirugía bucal. 28(4). e362–e370. 1 indexed citations
3.
Brand, H.S., et al.. (2023). Dutch dental hygiene students' knowledge of HPV‐related oropharyngeal squamous cell carcinoma and HPV vaccination. International Journal of Dental Hygiene. 22(1). 130–139. 1 indexed citations
4.
Karagozoglu, K. Hakki, Joost Bot, Seunghee Cha, et al.. (2023). Intraoperative Visualization and Treatment of Salivary Gland Dysfunction in Sjögren’s Syndrome Patients Using Contrast-Enhanced Ultrasound Sialendoscopy (CEUSS). Journal of Clinical Medicine. 12(12). 4152–4152. 2 indexed citations
6.
Jager, D.H.J., et al.. (2022). Correlations of palatal surface area with anthropometric dimensions of the head and face. Surgical and Radiologic Anatomy. 44(9). 1261–1267. 1 indexed citations
7.
Fortuna, Giulio, Kathleen Sullivan, Ivan Alajbeg, et al.. (2022). Impact of medications on salivary flow rate in patients with xerostomia: a retrospective study by the Xeromeds Consortium. Clinical Oral Investigations. 27(1). 235–248. 13 indexed citations
8.
Jager, D.H.J., et al.. (2020). Regional differences in perceived oral dryness as determined with a newly developed questionnaire, the Regional Oral Dryness Inventory. Clinical Oral Investigations. 24(11). 4051–4060. 17 indexed citations
10.
Jager, D.H.J., et al.. (2018). Tooth loss in Sjogren’s syndrome patients compared to age and gender matched controls. Medicina oral, patología oral y cirugía bucal. 23(5). 0–0. 10 indexed citations
11.
Karagozoglu, K. Hakki, et al.. (2018). Sialendoscopy enhances salivary gland function in Sjögren's syndrome: a 6-month follow-up, randomised and controlled, single blind study. Annals of the Rheumatic Diseases. 77(7). 1025–1031. 28 indexed citations
12.
Brand, H.S., et al.. (2017). Prevention of HPV-Related Oral Cancer by Dentists: Assessing the Opinion of Dutch Dental Students. Journal of Cancer Education. 33(6). 1347–1354. 36 indexed citations
13.
Czink, Elena, Christoph Heining, Theresia Weber, et al.. (2016). Dauerhafte Remission unter dualer HER2-Blockade mit Trastuzumab und Pertuzumab bei metastasiertem Gallenblasenkarzinom. Zeitschrift für Gastroenterologie. 54(5). 426–430. 15 indexed citations
14.
Jager, D.H.J., et al.. (2016). Sialendoscopy of Salivary Glands Affected by Sjögren Syndrome: A Randomized Controlled Pilot Study. Journal of Oral and Maxillofacial Surgery. 74(6). 1167–1174. 25 indexed citations
15.
Karagozoglu, K. Hakki, Jan G. de Visscher, Tymour Forouzanfar, E.H. van der Meij, & D.H.J. Jager. (2016). Complications of Sialendoscopy in Patients With Sjögren Syndrome. Journal of Oral and Maxillofacial Surgery. 75(5). 978–983. 9 indexed citations
16.
Wolff, Jan, Elisabet Farré-Guasch, George K.B. Sándor, et al.. (2016). Soft Tissue Augmentation Techniques and Materials Used in the Oral Cavity. Implant Dentistry. 25(3). 427–434. 29 indexed citations
17.
Jager, D.H.J., A.M. Vieira, J. Ruben, & M.C.D.N.J.M. Huysmans. (2012). Estimated erosive potential depends on exposure time. Journal of Dentistry. 40(12). 1103–1108. 30 indexed citations
18.
Huysmans, M.C.D.N.J.M., et al.. (2011). Reduction of Erosive Wear in situ by Stannous Fluoride-Containing Toothpaste. Caries Research. 45(6). 518–523. 60 indexed citations
19.
Al-Batran, Salah-Eddin, Akin Atmaca, D.H.J. Jager, et al.. (2004). Dose Escalation Study for Defining the Maximum Tolerated Dose of Continuous Oral Trofosfamide in Pretreated Patients with Metastatic Lung Cancer. Oncology Research and Treatment. 27(6). 534–538. 3 indexed citations
20.
Hofheinz, Ralf‐Dieter, Salah‐Eddin Al‐Batran, Frank Hartmann, et al.. (2003). Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer. Oncology Research and Treatment. 26(1). 44–48. 289 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026